| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Apellis Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 11.2K | $381K | $66.30 | Jan 1, 2025 | Direct |
| Apellis Pharmaceuticals, Inc. | Director | Common Stock | 22.7K | $314K | $13.85 | Jan 1, 2025 | Direct |
| GELESIS HOLDINGS, INC. | Director | Common Stock | 53.8K | May 6, 2022 | Direct | ||
| Amylyx Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 25K | Jun 5, 2025 | Direct | ||
| COVETRUS, INC. | Director | Common Stock | 0 | $20.88 | Oct 13, 2022 | Direct | |
| COVETRUS, INC. | Director | Restricted Stock Units | 0 | Oct 13, 2022 | Direct |